Cenci, Angela,
Mechanisms of L-DOPA-induced dyskinesia in Parkinson's disease [electronic resource] / Mechanisms of L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia in Parkinson's disease Angela Cenci. - London : Henry Stewart Talks, 2014. - 1 online resource (1 streaming video file (44 min.) : color, sound). - Parkinson's disease, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Parkinson's disease. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Characteristics of Parkinson´s disease (PD) -- Dysregulation of dopamine release and re-uptake in the striatum -- L-DOPA as a drug for PD -- L-DOPA-induced dyskinesia (LID) -- Pre- and post-synaptic mechanisms of LID -- Serotonin neurons, dopamine and LID -- Genes linked to involuntary movements (ΔFosB, ERK1/2, mGluR5) -- Spiny projection neurons (SPNs) in PD and LID.
Access restricted to subscribers.
Mode of access: World Wide Web.
3769 Henry Stewart Talks
Antiparkinsonian agents--Side effects.
Dopa--Physiological effect.
Parkinson's disease--Chemotherapy.
Parkinson's disease--Treatment.
Antiparkinson Agents--therapeutic use.
Antiparkinson Agents--toxicity.
Dyskinesia, Drug-Induced--physiopathology.
Dyskinesia, Drug-Induced--therapy.
Levodopa--toxicity.
Parkinson Disease--drug therapy.
Parkinson Disease--physiopathology.
Parkinson Disease--therapy.
Mechanisms of L-DOPA-induced dyskinesia in Parkinson's disease [electronic resource] / Mechanisms of L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia in Parkinson's disease Angela Cenci. - London : Henry Stewart Talks, 2014. - 1 online resource (1 streaming video file (44 min.) : color, sound). - Parkinson's disease, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Parkinson's disease. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Characteristics of Parkinson´s disease (PD) -- Dysregulation of dopamine release and re-uptake in the striatum -- L-DOPA as a drug for PD -- L-DOPA-induced dyskinesia (LID) -- Pre- and post-synaptic mechanisms of LID -- Serotonin neurons, dopamine and LID -- Genes linked to involuntary movements (ΔFosB, ERK1/2, mGluR5) -- Spiny projection neurons (SPNs) in PD and LID.
Access restricted to subscribers.
Mode of access: World Wide Web.
3769 Henry Stewart Talks
Antiparkinsonian agents--Side effects.
Dopa--Physiological effect.
Parkinson's disease--Chemotherapy.
Parkinson's disease--Treatment.
Antiparkinson Agents--therapeutic use.
Antiparkinson Agents--toxicity.
Dyskinesia, Drug-Induced--physiopathology.
Dyskinesia, Drug-Induced--therapy.
Levodopa--toxicity.
Parkinson Disease--drug therapy.
Parkinson Disease--physiopathology.
Parkinson Disease--therapy.